“…Human induced pluripotent stem cells (hiPSCs) provide a promising alternative, allowing the creation of SCZ patient-specific disease models to explore cellular and molecular phenotypes (Angulo Salavarria et al, 2023). Indeed, hiPSCs enable the generation of various brain-specific cell types, including cortical neurons, interneurons, astrocytes, and microglia (Abud et al, 2017; Muffat et al, 2016; Dell’Amico et al 2023). Several studies identified impaired neuronal maturation, reduction of neurite length and outgrowth through these cellular populations, along with an excitatory-inhibitory imbalance, including enhanced GABAergic-related neuronal expression and genetic upregulation (Brennand et al, 2011; Park et al, 2020; Sawada et al, 2020).…”